New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 27, 2014
15:12 EDTDANOY, HSP, NSRGY, FMS Hospira in talks to acquire Danone medical nutrition business, FT says
French consumer company Danone (DANOY) has been in negotiations to sell its medical nutrition business to Hospira (HSP) in a deal said to value the unit at $5B, says the Financial Times. The deal would also allow for U.S. based Hospira to domicile its tax base in Europe in a tax strategy known as an inversion, added the Financial Times. In prior reports, Nestle (NSRGY) and Fresenius (FMS) have also been mentioned as suitors for the Danone unit. Reference Link
News For DANOY;HSP;NSRGY;FMS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 22, 2014
13:35 EDTFMSFresenius Medical acquires National Cardiovascular Partners
Fresenius Medical Care announced the acquisition of National Cardiovascular Partners, or NCP. The parties involved agreed not to disclose the financial terms of the acquisition. The company expects NCP to generate in excess of $200M in revenue in 2015 and expects the investment to be accretive to earnings in the first year after closing. The investment will be financed through available cash and committed credit facilities, supplemented by additional debt financing. NCP is the leading operator of endovascular, vascular and cardiovascular services in the comfort and convenience of the outpatient setting. In partnership with over 200 physicians, NCP operates 21 outpatient vascular centers in six states.
07:21 EDTHSPU.S. DHS investigates medical gear for potential cyber defects, Reuters says
Subscribe for More Information
October 20, 2014
16:20 EDTDANOYOn The Fly: Closing Wrap
Subscribe for More Information
12:37 EDTDANOYOn The Fly: Midday Wrap
Subscribe for More Information
10:14 EDTDANOYMead Johnson volatility elevated, Danone not carrying out a review for takeover
Subscribe for More Information
09:22 EDTDANOYOn The Fly: Pre-market Movers
Subscribe for More Information
08:04 EDTHSPGerman fund pressured to sell Mylan stake over drug used in executions, FT says
Subscribe for More Information
06:00 EDTDANOYDanone acquisition of Mead would not be well received, says Bernstein
Subscribe for More Information
October 19, 2014
14:18 EDTDANOY, HSP, FMSFresenius, others explore bid for Danone medical nutrition unit, Reuters says
Subscribe for More Information
13:21 EDTDANOYDanone says not carrying out review on Mead Johnson takeover, Reuters says
In response to reports on Friday that French food company Danone (DANOY) was pursuing a takeover of pediatric nutrition company Mead Johnson (MJN), Danone made a statement on Sunday saying that it was not carrying out a review of a Mead Johnson takeover, says Reuters. Reference Link
October 17, 2014
16:17 EDTDANOYOn The Fly: Closing Wrap
Subscribe for More Information
12:57 EDTDANOYDanone to pursue takeover of Mead Johnson, sources say, Reuters reports
Subscribe for More Information
12:36 EDTDANOYDanone will pursue Mead Johnson takeover, sources say, Reuters reports
Subscribe for More Information
October 16, 2014
05:29 EDTNSRGYNestle reports FY outlook unchanged
Subscribe for More Information
05:28 EDTNSRGYNestle reports 9 month sales of CHF 66.2B
Subscribe for More Information
October 15, 2014
08:28 EDTDANOYDanone reports Q3 like-for-like sales up 6.9% to EU 5.42B
Danone confirmed its 2014 targets of sale growth between 4.5%-5.5%, trading operating margin stable within a range of down 20bps and up 20bps and free cash-flow of around EU 1.5B excluding exceptional items.
October 14, 2014
11:23 EDTHSPBIND Therapeutics and The Conference Forum hold a conference
Subscribe for More Information
October 10, 2014
10:01 EDTFMSOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:09 EDTFMSFresenius Medical upgraded to Buy from Neutral at BofA/Merrill
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use